• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Network meta-regression for ordinal outcomes: Applications in comparing Crohn's disease treatments.有序结局的网络Meta回归:在比较克罗恩病治疗方法中的应用
Stat Med. 2020 Mar 12. doi: 10.1002/sim.8518.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
4
Cannabis for the treatment of Crohn's disease.大麻用于治疗克罗恩病。
Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD012853. doi: 10.1002/14651858.CD012853.pub2.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD000542. doi: 10.1002/14651858.CD000542.pub2.
7
Aminosalicylates for induction of remission or response in Crohn's disease.用于诱导克罗恩病缓解或反应的氨基水杨酸盐。
Cochrane Database Syst Rev. 2016 Jul 3;7(7):CD008870. doi: 10.1002/14651858.CD008870.pub2.
8
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.比较生物疗法在诱导瘘管性克罗恩病缓解和应答中的疗效:系统评价和随机对照试验的网络荟萃分析。
Inflamm Bowel Dis. 2023 Mar 1;29(3):367-375. doi: 10.1093/ibd/izac103.
9
Bayesian network meta-regression hierarchical models using heavy-tailed multivariate random effects with covariate-dependent variances.使用具有协变量依赖方差的重尾多元随机效应的贝叶斯网络meta回归分层模型。
Stat Med. 2021 Jul 10;40(15):3582-3603. doi: 10.1002/sim.8983. Epub 2021 Apr 12.
10
Comparative efficacy and safety of combination therapy with infliximab for Crohn's disease: a systematic review and network meta-analysis.比较英夫利昔单抗联合治疗克罗恩病的疗效和安全性:系统评价和网络荟萃分析。
Int J Colorectal Dis. 2023 Mar 27;38(1):82. doi: 10.1007/s00384-023-04378-w.

引用本文的文献

1
Do the combined blood pressure effects of exercise and antihypertensive medications add up to the sum of their parts? A systematic meta-review.运动和降压药物对血压的综合影响是否等于它们各自影响的总和?一项系统的Meta综述。
BMJ Open Sport Exerc Med. 2021 Jan 20;7(1):e000895. doi: 10.1136/bmjsem-2020-000895. eCollection 2021.
2
Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol lowering drugs.贝叶斯推断用于网络荟萃回归的多元随机效应模型及其在降胆固醇药物中的应用
Biostatistics. 2019 Jul 1;20(3):499-516. doi: 10.1093/biostatistics/kxy014.

本文引用的文献

1
Residuals and Diagnostics for Ordinal Regression Models: A Surrogate Approach.有序回归模型的残差与诊断:一种替代方法。
J Am Stat Assoc. 2018;113(522):845-854. doi: 10.1080/01621459.2017.1292915. Epub 2018 Jun 6.
2
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases.I/II 型细胞因子、Janus激酶与自身免疫性疾病的治疗新策略
Nat Rev Rheumatol. 2016 Jan;12(1):25-36. doi: 10.1038/nrrheum.2015.167. Epub 2015 Dec 3.
3
Ranking treatments in frequentist network meta-analysis works without resampling methods.在频率主义网络荟萃分析中对治疗方法进行排序无需重采样方法即可实现。
BMC Med Res Methodol. 2015 Jul 31;15:58. doi: 10.1186/s12874-015-0060-8.
4
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.蒙歌根,一种口服 SMAD7 反义寡核苷酸,与克罗恩病。
N Engl J Med. 2015 Mar 19;372(12):1104-13. doi: 10.1056/NEJMoa1407250.
5
Triazolopyridines as selective JAK1 inhibitors: from hit identification to GLPG0634.三唑并吡啶类作为选择性 JAK1 抑制剂:从苗头化合物的确立到 GLPG0634。
J Med Chem. 2014 Nov 26;57(22):9323-42. doi: 10.1021/jm501262q. Epub 2014 Nov 17.
6
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.英夫利昔单抗诱导治疗对肿瘤坏死因子拮抗剂治疗失败的克罗恩病患者的影响。
Gastroenterology. 2014 Sep;147(3):618-627.e3. doi: 10.1053/j.gastro.2014.05.008. Epub 2014 May 21.
7
Graphical tools for network meta-analysis in STATA.STATA 中的网络荟萃分析图形工具。
PLoS One. 2013 Oct 3;8(10):e76654. doi: 10.1371/journal.pone.0076654. eCollection 2013.
8
Vedolizumab as induction and maintenance therapy for Crohn's disease.维得利珠单抗作为克罗恩病的诱导缓解和维持治疗药物。
N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739.
9
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.乌司奴单抗诱导和维持治疗难治性克罗恩病。
N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572.
10
Obtaining evidence by a single well-powered trial or several modestly powered trials.通过一项功效强大的单一试验或几项功效适度的试验来获取证据。
Stat Methods Med Res. 2016 Apr;25(2):538-52. doi: 10.1177/0962280212461098. Epub 2012 Oct 14.

有序结局的网络Meta回归:在比较克罗恩病治疗方法中的应用

Network meta-regression for ordinal outcomes: Applications in comparing Crohn's disease treatments.

作者信息

Gwon Yeongjin, Mo May, Chen Ming-Hui, Chi Zhiyi, Li Juan, Xia Amy H, Ibrahim Joseph G

机构信息

Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Amgen Inc., Thousand Oaks, California, USA.

出版信息

Stat Med. 2020 Mar 12. doi: 10.1002/sim.8518.

DOI:10.1002/sim.8518
PMID:32166784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7727029/
Abstract

Crohn's disease (CD) is a life-long condition associated with recurrent relapses characterized by abdominal pain, weight loss, anemia, and persistent diarrhea. In the US, there are approximately 780 000 CD patients and 33 000 new cases added each year. In this article, we propose a new network meta-regression approach for modeling ordinal outcomes in order to assess the efficacy of treatments for CD. Specifically, we develop regression models based on aggregate covariates for the underlying cut points of the ordinal outcomes as well as for the variances of the random effects to capture heterogeneity across trials. Our proposed models are particularly useful for indirect comparisons of multiple treatments that have not been compared head-to-head within the network meta-analysis framework. Moreover, we introduce Pearson residuals and construct an invariant test statistic to evaluate goodness-of-fit in the setting of ordinal outcome data. A detailed case study demonstrating the usefulness of the proposed methodology is carried out using aggregate ordinal outcome data from 16 clinical trials for treating CD.

摘要

克罗恩病(CD)是一种终身性疾病,伴有反复发作,其特征为腹痛、体重减轻、贫血和持续性腹泻。在美国,约有78万克罗恩病患者,且每年新增3.3万病例。在本文中,我们提出一种用于对有序结果进行建模的新网络meta回归方法,以评估克罗恩病治疗方法的疗效。具体而言,我们基于聚合协变量开发回归模型,用于有序结果的潜在切点以及随机效应的方差,以捕捉各试验间的异质性。我们提出的模型对于在网络meta分析框架内未进行直接比较的多种治疗方法的间接比较特别有用。此外,我们引入Pearson残差并构建一个不变检验统计量,以评估有序结果数据背景下的拟合优度。使用来自16项治疗克罗恩病的临床试验的聚合有序结果数据进行了详细的案例研究,以证明所提出方法的实用性。